US pharmaceutical multinational walks away after controversial £69bn bid rejected, wiping £7bn off British firm's share value One of the most bitterly contested takeover battles for a British firm in years has ended in recrimination as the US drugmaker Pfizer was forced to walk away from a £69bn bid for AstraZeneca, sparking protests from some City institutions. Scientists, unions and politicians on both sides of the Atlantic had lined up to criticise a deal they said was motivated by tax avo...
US pharmaceutical multinational walks away after controversial £69bn bid rejected, wiping £7bn off British firm's share value One of the most bitterly contested takeover battles for a British firm in years has ended in recrimination as the US drugmaker Pfizer was forced to walk away from a £69bn bid for AstraZeneca, sparking protests from some City institutions. Scientists, unions and politicians on both sides of the Atlantic had lined up to criticise a deal they said was motivated by tax avo...
Share this Article
Recommended